Department of Nutrition and Dietetics, Harokopio University, 70 Eleftheriou Venizelou Avenue Kallithea, 17671 Athens, Greece.
Cardiology Department, Onassis Cardiac Surgery Center, 17674 Athens, Greece.
Nutrients. 2022 Mar 25;14(7):1377. doi: 10.3390/nu14071377.
Evidence from research studies reports that wine consumption is associated with lower cardiovascular disease risk, partly through the amelioration of oxidative stress. The aim of the present study was to examine the effect of regular light to moderate wine consumption from coronary heart disease (CHD) patients compared to the effect induced by alcohol intake without the presence of wine microconstituents, on oxidation-induced macromolecular damage as well as on endogenous antioxidant enzyme activity. A randomized, single-blind, controlled, three-arm parallel intervention was carried out, in which 64 CHD patients were allocated to three intervention groups. Group A consumed no alcohol, and Group B (wine) and Group C (ethanol) consumed 27 g of alcohol/day for 8 weeks. Blood and urine samples were collected at baseline and at 4 and 8 weeks. Urine oxidized guanine species levels, protein carbonyls, thiobarbituric acid substances (TBARS) levels, as well as superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities, were measured. Oxidized guanine species and protein carbonyl levels were significantly increased in the ethanol group during the intervention and were significantly decreased in the wine group. These results support the idea that wine's bioactive compounds may exert antioxidant actions that counteract the macromolecular oxidative damage induced by alcohol in CHD patients.
研究报告的证据表明,葡萄酒的消费与降低心血管疾病的风险有关,部分原因是通过改善氧化应激。本研究的目的是检验从冠心病(CHD)患者中定期适量饮用葡萄酒与单纯摄入酒精(不含有葡萄酒的微量成分)对氧化诱导的大分子损伤以及内源性抗氧化酶活性的影响。采用随机、单盲、对照、三臂平行干预的方法,将 64 名 CHD 患者分为三组。A 组不饮酒,B 组(葡萄酒)和 C 组(乙醇)分别在 8 周内每天饮用 27 克酒精。在基线、4 周和 8 周时采集血液和尿液样本。测定尿液氧化鸟嘌呤水平、蛋白质羰基、硫代巴比妥酸物质(TBARS)水平以及超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GPx)的活性。在干预期间,乙醇组的氧化鸟嘌呤和蛋白质羰基水平显著升高,而葡萄酒组的这两种水平显著降低。这些结果支持了葡萄酒的生物活性化合物可能发挥抗氧化作用,抵消酒精对 CHD 患者大分子氧化损伤的观点。